Last updated: April 26, 2021
Sponsor: University of Aarhus
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neurologic Disorders
Treatment
N/AClinical Study ID
NCT04865185
TLH21
Ages 18-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy subjects
- Age between 18 and 40 years
- Participant is able and willing to give informed consent.
Exclusion
Exclusion Criteria:
- Unable to understand and speak Danish
- Non-cooperative
- Chronic pain or acute pain the past week lasting more than 4 hours or pain on the dayof investigation
- Pain medication within the last week
- Medication within the last week that can affect assessment
- Psychiatric or neurological disease and diseases that may affect the assessment
- Sensory disturbances
- History or symptoms of significant diseases (e.g. psychiatric or neurological disease,diseases that may affect the assessment, sensory disturbances, cancer, diabetesmellitus, liver diseases, kidney diseases, cardiovascular diseases)
- Pregnancy or lactation
- Jetlag or sleep deprivation
- Alcohol or drug abuse
- Consumption of cannabis the last 4 weeks and consumption of alcohol in the last 48hours
- Any abnormality of the skin or of vascular origin at application site
- History of hypersensitivity to lidocaine, other amide-type anesthetics, or othercontents of the lidocaine or vehicle
Study Design
Total Participants: 60
Study Start date:
March 01, 2021
Estimated Completion Date:
February 28, 2022
Study Description
Connect with a study center
Danish Pain Research Center, Aarhus University, Aarhus University Hospital
Aarhus N, 8200
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.